A paper published in the International Journal of Clinical Practice, has concluded: "The specific and significant COVID-19 risk of ADE [Antibody Dependent Enhancement] should have been and should be prominently and independently disclosed to research subjects currently in vaccine trials, as well as those being recruited for the trials and future patients after vaccine approval, in order to meet the medical ethics standard of patient comprehension for informed consent".
ADE is thew idea that there can be a paradoxical immune effects generated by vaccines, where produced antibodies actually aid the disease in question. The paper apart from addressing the issue of the lack of informed consent, concludes that there is evidence that Covid-19 vaccines could "worsen disease upon exposure to challenge or circulating virus".
